STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure

B-type natriuretic peptide (BNP) possesses blood-pressure–lowering, antifibrotic, and aldosterone-suppressing properties. In Stage A and B heart failure, the carriers of the minor C allele of the BNP genetic variant rs198389 have higher circulating levels of BNP and are at decreased risk of hyperten...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannone, Valentina, Ledwidge, Mark, Watson, Chris, McKie, Paul M., Burnett, John C., McDonald, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246026/
https://www.ncbi.nlm.nih.gov/pubmed/34222720
http://dx.doi.org/10.1016/j.jacbts.2021.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246026/
https://www.ncbi.nlm.nih.gov/pubmed/34222720
http://dx.doi.org/10.1016/j.jacbts.2021.05.001

Ejemplares similares